Lung Cancer Clinical Trials in Hwasun
3 recruitingHwasun, South Korea
Showing 1–3 of 3 trials
Recruiting
Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Non-small Cell Lung CancerNSCLCNSCLC (Advanced Non-small Cell Lung Cancer)+2 more
Revolution Medicines, Inc.420 enrolled129 locationsNCT06881784
Recruiting
Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions
Lung Cancer
Seoul National University Bundang Hospital1,240 enrolled11 locationsNCT05804786
Recruiting
Phase 2
Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-squamous Non-small Cell Lung Cancer
CrystalGenomics, Inc.60 enrolled8 locationsNCT05841472